or Try an Advanced Search...

    Technical Analysis for KRBP - Kiromic BioPharma, Inc.

    Grade Last Price % Change Price Change
    F 0.90 -10.00% -0.10
    KRBP closed down 10.0 percent on Tuesday, November 19, 2024, on 2.89 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical KRBP trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Pocket Pivot Bullish Swing Setup -10.00%
    Volume Surge Other -10.00%
    Wide Bands Range Expansion -10.00%
    Gapped Up Strength -10.00%
    Oversold Stochastic Weakness -10.00%
    Narrow Range Bar Range Contraction -8.16%
    Older End-of-Day Signals for KRBP ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace 2 days ago
    1.5x Volume Pace 2 days ago
    3x Volume Pace 2 days ago
    Down 5% 2 days ago
    Down 3% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    KRBP Chart by TradingView
    Basic chart:

    Profile

    Kiromic BioPharma, Inc. operates as a biotechnology company. The Company focuses on target discovery and gene editing through artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma serves customers in the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Artificial Intelligence Neural Network

    Is KRBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 8 Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01
    Oct 1 Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial
    Sep 19 Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
    Sep 19 Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous Recommendation
    Aug 14 Kiromic stock soars 65% on FDA fast track status for Deltacel
    Aug 14 Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation
    Aug 12 Kiromic reports update from Phase I NSCLC treatment trial
    Aug 9 Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial
    Aug 1 Kiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01
    Jul 18 Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase
    See more KRBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.78
    52 Week Low 0.16
    Average Volume 1,480
    200-Day Moving Average 1.99
    50-Day Moving Average 1.61
    20-Day Moving Average 1.22
    10-Day Moving Average 1.01
    Average True Range 0.13
    RSI (14) 33.77
    ADX 38.02
    +DI 25.64
    -DI 50.17
    Chandelier Exit (Long, 3 ATRs) 1.37
    Chandelier Exit (Short, 3 ATRs) 1.28
    Upper Bollinger Bands 1.68
    Lower Bollinger Band 0.76
    Percent B (%b) 0.15
    BandWidth 75.50
    MACD Line -0.23
    MACD Signal Line -0.22
    MACD Histogram -0.01
    Fundamentals Value
    Market Cap 1.13 Million
    Num Shares 1.26 Million
    EPS -19.51
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 0.00
    Price-to-Book 11.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.90
    Resistance 3 (R3) 0.90 0.90 0.90
    Resistance 2 (R2) 0.90 0.90 0.90 0.90
    Resistance 1 (R1) 0.90 0.90 0.90 0.90 0.90
    Pivot Point 0.90 0.90 0.90 0.90 0.90
    Support 1 (S1) 0.90 0.90 0.90 0.90 0.90
    Support 2 (S2) 0.90 0.90 0.90 0.90
    Support 3 (S3) 0.90 0.90 0.90
    Support 4 (S4) 0.90